103 / 510
Cuidados
Continuos
102
BIBLIOGRAFIA
Jean-PierreP, MorrowGR, Roscoe JAet al. Aphase 3 randomized, placebo-controlled, doubleblind,
clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving
chemotherapy. Cancer 2010;116:3513–3520.
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Cancer
Related Fatigue version 1.2014. En www. nccn.org. Acceso 31 Marzo 2014.
Cella D, Davis K, Breitbart W et al. Cancer-related fatigue: Prevalence of proposed
diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001; 19:3385–
3391.
Cella DF, Peterman A, Passik S et al. Progress toward guidelines for the management of fatigue.
Oncology 1998; 62:369 –377.
Hofman M, Morrow GR, Roscoe JA, et al. Cancer patients expectations of experiencing
treatment-related side effects: A University of Rochester Cancer Center-Community Clinical
Oncology Program study of 938 patients from community practices. Cancer 2004; 101:851-
857.
Kirkova J, Aktas A, Walsh D et al. Cancer symptom clusters: Clinical and research methodology. J
Palliat Med 2011;14:1149 –1166.
Barsevick AM, Cleeland CS, Manning DC et al. ASCPRO recommendations for the assessment
of fatigue as an outcome in clinical trials. J Pain Symptom Manage 2010;39:1086 –
1099.
Minton O, Stone PC .Asystematic review of the scales used for the measurement of cancer- related
fatigue (CRF). Ann Oncol 2009;20:17–25.
Ryan JL, Carroll JK, Ryan EP et al. Mechanisms of cancer-related fatigue. The Oncologist
2007; 12(suppl 1):22–34.
Seruga B, Zhang H, Bernstein LJ et al. Cytokines and their relationship to the symptoms and
outcome of cancer. Nat Rev Cancer 2008; 8:887– 899.
Fontes-Oliveira CC, Busquets S, Toledo M, et al. Mitochondrial and sarcoplasmic reticulum
abnormalities in cancer cachexia: Altered energetic efficiency? Biochim Biophys Acta 2013;
1830:2770 –2778.
Alexander S, Minton O, Andrews P, et al. A comparison of the characteristics of disease- free breast
cancer survivors with or without cancer-related fatigue syndrome Eur J Cancer
2009;45:384 –392.
Bower JE, Ganz PA, Irwin MR, et al. Fatigue and gene expression in human leukocytes: Increased
NF-kB and increased glucocorticoid signalling in breast cancer survivors with persistent fatigue.
Brain Behav Immune 2011;25:147–150.
Bower JE, Ganz PA, Aziz N et al. Fatigue and pro-inflammatory cytokine activity in breast cancer
survivors. Psychosom Med 2002;64:604–611.
Jager A, Sleijfer S, Rijt van der CCD. The pathogenesis of cancer related fatigue: Could increased
activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer
2008;44:175–181.
Graydon JE, Bubela N, Irvine D et al. Fatigue reducing strategies used by patients receiving
treatment for cancer. Cancer Nurs 1995; 18:23–28.
Goedendorp MM, Gielissen MF, Verhagen CA et al. Psychosocial interventions for reducing fatigue
during cancer treatment in adults. Cochrane Database Syst Rev 2009:1;CD006953.
Carroll JK, Kohli S, Mustian KM, et al. Pharmacologic treatment of cancer-related fatigue. The
Oncologist 2007; 12 (suppl 1): 43-51
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.